Matteo Bellia

5PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Humoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Oct 16, 2025
Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy.

Mattia Schipani, Matteo Bellia, Carola Sella

|Jun 30, 2025
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV-Positive Patient: A Case Report.

Matteo Bellia, Riccardo Moia, Mattia Schipani

|Jan 18, 2025
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Riccardo Moia, Donatella Talotta, Lodovico Terzi Di Bergamo

|Oct 28, 2024
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab.

Matteo Bellia, Mariangela Greco, Monia Lunghi

Pageof 1

Frequent Collaborators

3 joint publications

Riccardo Moia

3 joint publications

Gianluca Gaidano

2 joint publications

Mohammad Almasri

2 joint publications

Chiara Cosentino